The Board has denied service connection for Chronic Myelogenous Leukemia (CML) as the evidence does not support a link to active service, including exposure to herbicides. The Veteran's CML was diagnosed in 2004, many years after his discharge from active duty.
The deciding factor: The VA examiner found no credible evidence linking the Veteran’s CML to his military service or any specific exposures during service.
- Claimed conditions
- Chronic Myelogenous Leukemia (CML)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- June 29, 2020
- Citation
- 20043575
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 20043575.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board granted a 100 percent rating for Chronic Myelogenous Leukemia from June 4, 2014 to September 27, 2018 and a 30 percent rating thereafter. The Veteran's CML was in remission during the latter period.
- Whole decision: Granted
The Veteran's service connection for Chronic Myelogenous Leukemia (CML) is granted. The issue of service connection for Behcet's Syndrome, due to presumed exposure at Camp Lejeune, is remanded.
- Whole decision: Granted
The Veteran is granted an effective date of August 7, 2023 for service connection of Chronic Myelogenous Leukemia (CML), which was denied in a previous rating decision. The claim was received within one year of the PACT Act's effective date and meets eligibility criteria.
- Whole decision: Denied
The Veteran's cause of death, respiratory failure and overwhelming sepsis with contributory hypotension, was attributed to his underlying Chronic Myelogenous Leukemia (CML), which developed as a result of the bone marrow transplant he underwent due to CML. The Board found that service connection for CML could not be established because there was no evidence showing it was incurred during or aggravated by service.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.